Clinical trials: Puberty, Precocious
- Condition Puberty, Precocious
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Early Puberty
The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1
A randomized, single-blinded, parallel design phase I clinical trial to investigate the safety and pharmacokinetics/pharmacodynamics of CKD-841 A-1, CKD-841 D or Leuplin Inj. after subcutaneous injection in postmenopausal female
- Trial name
- NCT04840745
- Testing
- CKD-841 A-1 3.75mg, CKD-841 A-1 1.88mg, CKD-841 D 2.92mg
- Where
- South Korea
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Chong Kun Dang Pharmaceutical